|Articles|July 14, 2014
MedNet Solutions Receives First Major Outside Financing
Funds to Accelerate iMedNet EDC Sales, Marketing and R&D Initiatives
Advertisement
MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, announced that Arrowroot Capital, a growth equity firm focused on software-as-a-service (SaaS) and Internet-based businesses, has made a $4 million investment in MedNet Solutions. This funding will be used to support the ongoing growth and development of both MedNet and iMedNet EDC, its flagship cloud-based eClinical technology platform.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
2
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
5